In accordance with IFRS 7, EUROMEDICA S.A. hereby informs its shareholders and investing public of the sensitivity analysis performed on the IASO share portfolio, which it had in its possession on 31/12/2007 and 30/3/2008.
Disclosure 31/12/2007:
The financial assets measured at fair value in the financial results accounts for which there exists an active market, based on which they may be measured at fair value, concern the possession of 5,202,331 shares of IASO S.A., which is listed on the Athens Exchange and whose total fair value on 31/12/2007 amounted to a total of euro 65,237,000 (based on the closing share price on the Athens Exchange trading day of 31/12/2007, euro 12.54). If on 31/12/2007 the closing price of the said shares was 1.00% higher/lower and the remaining variables remained fixed, then the after-tax financial results for the 2007 fiscal year and the net worth of the Group would be higher/lower by approximately euro 489,000.
Disclosure 31/3/2008:
The balance of the financial assets measured at fair value in the financial results accounts (shares listed on the Athens Exchange) concern the book value of 5,353,214 (31/12/2007: 5,202,331) shares of IASO S.A. In the first quarter of 2008 the Group had acquired an additional 150,883 shares of IASO S.A. in exchange for the total amount of euro 2,992,000. The valuation of the 5,353,214 shares at the end of the first quarter of 2008 resulted in a loss of euro 14,954,000 (2007: euro 1,701,000 profit), which was recorded in the financial results. It is noted that if on 31/3/2008 the closing price of the said shares was 1.00% higher/lower and the remaining variables remained fixed, then the after-tax financial results for the interim period of the first quarter of 2008 and the net worth of the Group would be higher/lower by approximately euro 401,000.